section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Endo: hypoglycemia

Neuro: dizziness, fatigue, headache

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

Hepatic/Renal Impairment

US Brand Names

Bystolic

Action

  • Blocks stimulation of beta adrenergic receptor sites; selective for beta1 (myocardial) receptors in most patients. In some patients (poor metabolizers), higher blood levels may result in some beta2 (pulmonary, vascular, uterine) adrenergic blockade.
Therapeutic effects:
  • Lowering of BP.

Classifications

Therapeutic Classification: antihypertensives

Pharmacologic Classification: beta blockers (selective)

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Unknown.

Protein Binding: 98%.

Metabolism/Excretion: Mostly metabolized by the liver via the CYP2D6 isoenzyme; the CYP2D6 enzyme system exhibits genetic polymorphism; 7% of population may be poor metabolizers and may have significantly nebivolol concentrations and an risk of adverse effects.; minimal excretion of unchanged drug.

Half-Life: Extensive metabolizers: 12 hr; Poor metabolizers: 19 hr.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown1.5–4 hr24 hr



Patient/Family Teaching

Pronunciation

ne-BI-vi-lol